Copyright/Subscription  by unknown
Editorial Ofﬁ ce. Value in Health Regional Issues, ISPOR, 505 Lawrence Square 
Blvd. South, Lawrenceville, NJ 08648.
ISPOR Ofﬁ ce. Nancy S. Berg, BSc, CEO/Executive Director, 
505 Lawrence Square Blvd. South, Lawrenceville, NJ 08648. Tel: (609) 
586-4981, Fax: (609) 586-4982, E-mail: info@ispor.org, Web site: 
http://www.ispor.org/publications/VIHRI/VIHRImain.asp
Value in Health Regional Issues (ISSN 2212-1099) is published 3 times a year 
on behalf of the International Society for Pharmacoeconomics and Outcomes 
Research by Elsevier Inc, 360 Park Avenue South, New York, NY 10010-1710.
POSTMASTER: Send address changes to, Value in Health Regional Issues, 
Elsevier Health Sciences Division, Subscription Customer Service, 3251 
Riverport Lane, Maryland Heights, MO 63043.
CUSTOMER SERVICE (orders, claims, online, change of address): Elsevier
Health Sciences Division, Subscription Customer Service, 3251 Riverport Lane,
Maryland Heights, MO 63043. Tel: (800) 654-2452 (U.S. and Canada); (314)
447-8871 (outside U.S. and Canada). Fax: (314) 447-8029. E-mail:
JournalsCustomerService-usa@elsevier.com (for print support);
JournalsOnlineSupport-usa@elsevier.com (for online support). Address changes
must be submitted four weeks in advance.
YEARLY SUBSCRIPTION RATES: All subscribers to the journal Value in Health 
automatically receive Value in Health Regional Issues. Value in Health Regional 
Issues is not available for separate subscription purchase. Single issues of Value 
in Health Regional Issues may be purchased via Elsevier Customer Service, 
using the contact details above.
Further information on this journal is available from the Publisher or from this
journal’s website (http://www.elsevier.com/locate/vhri). Information on other
Elsevier products is available through Elsevier’s website (http://www.
elsevier.com).
Author inquiries
For inquiries relating to the submission of articles (including electronic
submission where available), visit http:/www.elsevier.com/authors. The site also
provides the facility to track accepted articles and set up e-mail alerts to inform
you of when an article’s status has changed, as well as detailed artwork 
 guidelines, copyright information, frequently asked questions, and more. Please
see Information for Authors for individual journal. Contact details for questions
arising after acceptance of an article, especially those relating to proofs, are
provided after registration of an article for publication.
English language help service: Upon request, Elsevier will direct authors to
an agent who can check and improve the English of their paper (before
submission). Please contact authorsupport@elsevier.com for further information.
Reprints. For queries about author offprints, e-mail authorsupport@
elsevier.com. To order 100 or more reprints for educational, commercial, or
promotional use, contact the Commercial Reprints Department, Elsevier Inc.,
360 Park Avenue South, New York, NY 10010-1710. Fax: (212) 462-1935; 
e-mail reprints@elsevier.com. Reprints of single articles available online may be
obtained by purchasing Pay-Per-View access for $36 per article on the journal
website http://www.elsevier.com/locate/vhri.
Copyright © 2014, International Society for Pharmacoeconomics and Outcomes
Research (ISPOR). Published by Elsevier Inc.
This journal and the individual contributions contained in it are protected under
copyright by International Society for Pharmacoeconomics and Outcomes
Research, and the following terms and conditions apply to their use:
Photocopying
Single photocopies of single articles may be made for personal use as allowed
by national copyright laws. Permission of the Publisher and payment of a fee is
required for all other photocopying, including multiple or systematic copying,
copying for advertising or promotional purposes, resale, and all forms of
document delivery. Special rates are available for educational institutions that
wish to make photocopies for non-proﬁ t educational classroom use.
Permissions may be sought directly from Elsevier’s Rights Department in
Oxford, UK: phone +44 (0) 1865 843830, fax +44 (0) 1865 853333. 
Requests may also be completed online via the Elsevier homepage 
(http://www.elsevier.com/authors/obtaining-permission-to-re-use-elsevier-material).
In the USA, users may clear permissions and make payments through the
Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923,
USA; phone: (978) 750-8400, fax: (978) 750-4744, and in the UK through the
Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham
Court Road, London W1P 0LP, UK; phone: (+44) 20 7631 5555; fax: (+44) 20
7631 5500. Other countries may have a local reprographic rights agency for
payments.
Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles
including abstracts for internal circulation within their institutions. Permission of
the Publisher is required for resale or distribution outside the institution.
Permission of the Publisher is required for all other derivative works, including
compilations and translations.
Electronic Storage or Usage
Permission of the Publisher is required to store or use electronically any
material contained in this journal, including any article or part of an article.
Except as outlined above, no part of this publication may be reproduced, stored
in a retrieval system or transmitted in any form or by any means, electronic,
mechanical, photocopying, recording or otherwise, without prior written
permission of the Publisher.
Address permissions requests to: Elsevier Rights Department, at the fax and
e-mail addresses noted above.
Abstracting and Indexing
Value in Health Regional Issues is indexed in SciVerse Scopus.
Notice
No responsibility is assumed by the Publisher or the International Society for
Pharmacoeconomics and Outcomes Research for any injury and/or damage to
persons or property as a matter of products liability, negligence or otherwise,
or from any use or operation of any methods, products, instructions or ideas
contained in the material herein. Because of rapid advances in the medical
sciences, in particular, independent veriﬁ cation of diagnoses and drug dosages
should be made.
Although all advertising material is expected to conform to ethical (medical)
standards, inclusion in this publication does not constitute a guarantee or
endorsement of the quality or value of such product or of the claims made of it
by its manufacturer.
